These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35219242)

  • 1. Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS.
    Etemadifar M; Salari M; Etemadifar MR; Sabeti F; Fateh ST; Aminzade Z
    Mult Scler Relat Disord; 2022 Apr; 60():103664. PubMed ID: 35219242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder.
    Cai MT; Zheng Y; Shen CH; Yang F; Fang W; Zhang YX; Ding MP
    Mult Scler; 2021 May; 27(6):871-882. PubMed ID: 32672091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency of longitudinally extensive transverse myelitis in MS: A population-based study.
    Asnafi S; Morris PP; Sechi E; Pittock SJ; Weinshenker BG; Palace J; Messina S; Flanagan EP
    Mult Scler Relat Disord; 2020 Jan; 37():101487. PubMed ID: 31707235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort.
    Rajput HM; Hassan M; Badshah M
    Mult Scler Relat Disord; 2023 Jun; 74():104656. PubMed ID: 37068371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation.
    Loos J; Pfeuffer S; Pape K; Ruck T; Luessi F; Spreer A; Zipp F; Meuth SG; Bittner S
    J Neurol; 2020 Jun; 267(6):1632-1642. PubMed ID: 32055995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint radiomics and spatial distribution model for MRI-based discrimination of multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin-oligodendrocyte-glycoprotein-IgG-associated disorder.
    Luo X; Li H; Xia W; Quan C; ZhangBao J; Tan H; Wang N; Bao Y; Geng D; Li Y; Yang L
    Eur Radiol; 2024 Jul; 34(7):4364-4375. PubMed ID: 38127076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole spinal transverse myelitis in neuromyelitis optica spectrum disorder.
    Etemadifar M; Mousavi S; Salari M; Hosseinian SA; Mansouri AR
    Mult Scler Relat Disord; 2024 Jul; 87():105666. PubMed ID: 38749352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis.
    Rocchi C; Forcadela M; Kelly P; Linaker S; Gibbons E; Bhojak M; Jacob A; Hamid S; Huda S
    Mult Scler; 2024 Mar; 30(3):345-356. PubMed ID: 38258822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.
    Pekcevik Y; Mitchell CH; Mealy MA; Orman G; Lee IH; Newsome SD; Thompson CB; Pardo CA; Calabresi PA; Levy M; Izbudak I
    Mult Scler; 2016 Mar; 22(3):302-11. PubMed ID: 26209588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis.
    Juryńczyk M; Klimiec-Moskal E; Kong Y; Hurley S; Messina S; Yeo T; Jenkinson M; Leite MI; Palace J
    J Neurol; 2022 Jan; 269(1):269-279. PubMed ID: 34043042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MS.
    Webb LM; Cacciaguerra L; Krecke KN; Chen JJ; Sechi E; Redenbaugh V; Dubey D; Pittock SJ; Flanagan EP
    J Neurol Sci; 2023 Jul; 450():120687. PubMed ID: 37201267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders.
    Hu H; You X; Ye J
    Mult Scler Relat Disord; 2018 Apr; 21():78-83. PubMed ID: 29499441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease.
    Salama S; Khan M; Levy M; Izbudak I
    Mult Scler Relat Disord; 2019 Apr; 29():15-22. PubMed ID: 30658259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical MOG antibody disease presenting with typical multiple sclerosis lesions.
    Dolbec K; Chalkley J; Sudhakar P
    Mult Scler Relat Disord; 2020 Sep; 44():102342. PubMed ID: 32615531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis.
    Hyun JW; Huh SY; Shin HJ; Woodhall M; Kim SH; Irani SR; Lee SH; Waters P; Kim HJ
    Mult Scler; 2019 Apr; 25(4):585-590. PubMed ID: 29512413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging in children with transverse myelitis and acquired demyelinating syndromes.
    El Naggar I; Cleaveland R; Wendel EM; Bertolini A; Schanda K; Karenfort M; Thiels C; Della Marina A; Schimmel M; Leiz S; Lechner C; Baumann M; Reindl M; Wegener-Panzer A; Rostásy K;
    Mult Scler Relat Disord; 2022 Nov; 67():104068. PubMed ID: 35933757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelitis in inflammatory disorders associated with myelin oligodendrocyte glycoprotein antibody and aquaporin-4 antibody: A comparative study in Chinese Han patients.
    ZhangBao J; Huang W; Zhou L; Wang L; Chang X; Lu C; Zhao C; Lu J; Quan C
    Eur J Neurol; 2021 Apr; 28(4):1308-1315. PubMed ID: 33220172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.